Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-11-08

FDA Approved: CLOMIPHENE CITRATE — Original Application (RISING PHARMA HOLDINGS, INC.)

View source ↗

Summary

FDA approved a generic clomiphene citrate product from Rising Pharma Holdings, Inc. under ANDA216739. It is indicated for infertility due to ovulatory dysfuncti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CLOMIPHENE CITRATE (CLOMIPHENE CITRTAE)

Snippet

ORIG AP for CLOMIPHENE CITRATE (CLOMIPHENE CITRTAE)